Authors

Deepak Mittal
Latest Article

A Practitioner’s Guide to AI Lifecycle Management in Life Sciences

This guide outlines a proven framework, spanning process, people, and platform, to help healthcare innovators scale AI with compliance, collaboration, and clinical impact in mind.

Grundfos
Latest Article

Machine Health in Pharmaceutical Production

Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.

Kirsten Newquist
Latest Article

How Smart Packaging and Emerging AI Tools Are Shaping the Future of Cold Chain Integrity

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, and Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explain how embedded product intelligence—paired with cautious, strategic adoption of AI—is redefining pharmaceutical cold chain reliability and supply-chain decision-making.

Shweta Maniar, Google Cloud

Director of Global Healthcare & Life Sciences Industry Strategy at Google Cloud.

Latest Article

Beyond the Hype: GenAI’s Real Impact on Life Sciences Manufacturing

Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.

Tina Martinez
Latest Article

How Integrated Solutions Deliver Measurable Value for Pharma Manufacturers

In the final part of her Pharma Commerce video interview, Tina Martinez, vice president and head of global products and solutions at Cencora, explains how streamlining clinical supply services, reducing fragmentation, and piloting data-driven tools like real-time adherence tracking are translating innovation into quantifiable efficiency, visibility, and commercial impact for manufacturers worldwide.

Ammie McAsey, McKesson

SVP of Customer Distribution Experience at McKesson. She leads the company’s distribution strategy across the US for brand, generic, and specialty pharmaceuticals.

Latest Article

Strategies to Modernize, Future-Proof, and Secure the Healthcare Supply Chain

Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.

Angie Franks, Kalderos
Latest Article

340B Litigation and the Path Toward Transparent Drug Discount Programs

As pharma drug pricing debates heat up, the 340B program faces mounting challenges from outdated regulations, duplicate discounts, and limited transparency.

SamaCare
Latest Article

How One Brand Protected Market Share Amid Biosimilar Pressure

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

Kamini Anbil
Latest Article

Multi-Indication Drug Branding in Today’s Pharmaceutical Industry

As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.

Matthew Sample
Latest Article

Understanding the FDA's Exemption for DSCSA Compliance

In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.